title: Association analysis of variants in the core promoter region of angiotensinogen gene with essential hypertension in Tibetan population.
abstract: OBJECTIVE
  To detect the variants in the core promoter region of angiotensinogen(AGT) gene, and to analyse the relationship between the AGT gene polymorphisms and essential hypertension in Tibetan population.
  
  
  METHODS
  This is a case-control study consisting of 103 essential hypertensive subjects and 82 normotensive controls matched by age and sex. The variants in the AGT gene core promoter region were screened by polymerase chain reaction/single strand conformation polymorphism(PCR/SSCP) and further identified by automated sequencing. The A(-6)G polymorphism was determined in DNA extracted from leucocytes by polymerase chain reaction/restriction fragment length polymorphism (PCR/RFLP).
  
  
  RESULTS
  (1) There were two different electrophoresis band patterns in PCR/SSCP analysis. PCR product direct sequencing showed that the two band patterns represented the AA, AC genotypes in the (-20) site of AGT gene respectively. The distribution of A(-20)C genotype was almost identical in essential hypertensive and normotensive groups (P>0.8). The A allele frequency was very high in both groups (control: 0.9175, hypertensive: 0.9124). (2)Distribution of genotype in the (-6) site of AGT gene was much different between the patient group and control group (P<0.005). The frequency of G allele was statistically higher in the patient group than in controls (0.374 vs 0.220, P<0.025).
  
  
  CONCLUSIONS
  Both Tibetan hypertensives and normotensives have higher frequency of A allele in AGT gene (-20) site. The higher frequency of G allele in the AGT gene (-6) site in Tibetan hypertension patients suggests that this allele may be the genetic susceptibility factor in the proceeding of essential hypertension in the Tibetan population.
authors.affiliation: Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences, School of Basic Medicine, Peking Union Medical College, Beijing, 100005 P. R. China. yang-chun@iname.com
authors.forename: C
authors.initials: C
authors.lastname: Yang
authors.forename: C
authors.initials: C
authors.lastname: Qiu
authors.forename: S
authors.initials: S
authors.lastname: Lu
authors.forename: W
authors.initials: W
authors.lastname: Cen
authors.forename: M
authors.initials: M
authors.lastname: Zhuo
authors.forename: C
authors.initials: C
authors.lastname: Cui
authors.forename: D
authors.initials: D
authors.lastname: Cai
authors.forename: X
authors.initials: X
authors.lastname: Zhu
authors.forename: Y
authors.initials: Y
authors.lastname: Liu
authors.forename: W
authors.initials: W
authors.lastname: Zhou
authors.forename: L
authors.initials: L
authors.lastname: Zhuang
authors.forename: D
authors.initials: D
authors.lastname: Ren
mesh_terms: D000808:Angiotensinogen / Q000235:genetics*; D016022:Case-Control Studies; D020022:Genetic Predisposition to Disease; D006801:Humans; D006973:Hypertension / Q000235:genetics*; D016133:Polymerase Chain Reaction; D011110:Polymorphism, Genetic; D018807:Polymorphism, Single-Stranded Conformational; D011401:Promoter Regions, Genetic; D018609:Tibet
chemical_list: D000808:Angiotensinogen